Faster access than browser!Similarities between Methylphenidate and Selective serotonin reuptake inhibitor
Methylphenidate and Selective serotonin reuptake inhibitor have 44 things in common (in Unionpedia): Agonist, Akathisia, Antidepressant, Attention deficit hyperactivity disorder, Bupropion, Chemical synapse, Clinical trial, Cognition, Coma, Depression (mood), Dopamine transporter, Food and Drug Administration, Heart arrhythmia, Hyperreflexia, Libido, Major depressive disorder, Mechanism of action, Monoamine oxidase inhibitor, Monoamine transporter, Mydriasis, Myocardial infarction, National Institute for Health and Care Excellence, Neurotransmitter, Norepinephrine transporter, Pethidine, Phenelzine, Placebo, Prenatal development, Priapism, Receptor (biochemistry), ..., Reuptake, Reuptake inhibitor, Serotonergic, Serotonin syndrome, Serotonin transporter, Side effect, Sigma-1 receptor, Stroke, Suicidal ideation, Tachycardia, Tranylcypromine, Tricyclic antidepressant, United Kingdom, 5-HT1A receptor. Expand index (14 more) »
Agonist
An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.
Agonist and Methylphenidate · Agonist and Selective serotonin reuptake inhibitor ·
Akathisia
Akathisia is a movement disorder characterized by a feeling of inner restlessness and inability to stay still.
Akathisia and Methylphenidate · Akathisia and Selective serotonin reuptake inhibitor ·
Antidepressant
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.
Antidepressant and Methylphenidate · Antidepressant and Selective serotonin reuptake inhibitor ·
Attention deficit hyperactivity disorder
Attention-deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type.
Attention deficit hyperactivity disorder and Methylphenidate · Attention deficit hyperactivity disorder and Selective serotonin reuptake inhibitor ·
Bupropion
Bupropion, sold under the brand names Wellbutrin and Zyban among others, is a medication primarily used as an antidepressant and smoking cessation aid.
Bupropion and Methylphenidate · Bupropion and Selective serotonin reuptake inhibitor ·
Chemical synapse
Chemical synapses are biological junctions through which neurons' signals can be exchanged to each other and to non-neuronal cells such as those in muscles or glands.
Chemical synapse and Methylphenidate · Chemical synapse and Selective serotonin reuptake inhibitor ·
Clinical trial
Clinical trials are experiments or observations done in clinical research.
Clinical trial and Methylphenidate · Clinical trial and Selective serotonin reuptake inhibitor ·
Cognition
Cognition is "the mental action or process of acquiring knowledge and understanding through thought, experience, and the senses".
Cognition and Methylphenidate · Cognition and Selective serotonin reuptake inhibitor ·
Coma
Coma is a state of unconsciousness in which a person cannot be awaken; fails to respond normally to painful stimuli, light, or sound; lacks a normal wake-sleep cycle; and does not initiate voluntary actions.
Coma and Methylphenidate · Coma and Selective serotonin reuptake inhibitor ·
Depression (mood)
Depression is a state of low mood and aversion to activity that can affect a person's thoughts, behavior, tendencies, feelings, and sense of well-being.
Depression (mood) and Methylphenidate · Depression (mood) and Selective serotonin reuptake inhibitor ·
Dopamine transporter
The dopamine transporter (also dopamine active transporter, DAT, SLC6A3) is a membrane-spanning protein that pumps the neurotransmitter dopamine out of the synaptic cleft back into cytosol.
Dopamine transporter and Methylphenidate · Dopamine transporter and Selective serotonin reuptake inhibitor ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and Methylphenidate · Food and Drug Administration and Selective serotonin reuptake inhibitor ·
Heart arrhythmia
Heart arrhythmia (also known as arrhythmia, dysrhythmia, or irregular heartbeat) is a group of conditions in which the heartbeat is irregular, too fast, or too slow.
Heart arrhythmia and Methylphenidate · Heart arrhythmia and Selective serotonin reuptake inhibitor ·
Hyperreflexia
Hyperreflexia (or hyper-reflexia) is defined as overactive or overresponsive reflexes.
Hyperreflexia and Methylphenidate · Hyperreflexia and Selective serotonin reuptake inhibitor ·
Libido
Libido, colloquially known as sex drive, is a person's overall sexual drive or desire for sexual activity.
Libido and Methylphenidate · Libido and Selective serotonin reuptake inhibitor ·
Major depressive disorder
Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.
Major depressive disorder and Methylphenidate · Major depressive disorder and Selective serotonin reuptake inhibitor ·
Mechanism of action
In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.
Mechanism of action and Methylphenidate · Mechanism of action and Selective serotonin reuptake inhibitor ·
Monoamine oxidase inhibitor
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Methylphenidate and Monoamine oxidase inhibitor · Monoamine oxidase inhibitor and Selective serotonin reuptake inhibitor ·
Monoamine transporter
Monoamine transporters (MATs) are protein structures that function as integral plasma-membrane transporters to regulate concentrations of extracellular monoamine neurotransmitters.
Methylphenidate and Monoamine transporter · Monoamine transporter and Selective serotonin reuptake inhibitor ·
Mydriasis
Mydriasis is the dilation of the pupil, usually having a non-physiological cause, or sometimes a physiological pupillary response.
Methylphenidate and Mydriasis · Mydriasis and Selective serotonin reuptake inhibitor ·
Myocardial infarction
Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle.
Methylphenidate and Myocardial infarction · Myocardial infarction and Selective serotonin reuptake inhibitor ·
National Institute for Health and Care Excellence
The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body of the Department of Health in the United Kingdom, which publishes guidelines in four areas.
Methylphenidate and National Institute for Health and Care Excellence · National Institute for Health and Care Excellence and Selective serotonin reuptake inhibitor ·
Neurotransmitter
Neurotransmitters are endogenous chemicals that enable neurotransmission.
Methylphenidate and Neurotransmitter · Neurotransmitter and Selective serotonin reuptake inhibitor ·
Norepinephrine transporter
The norepinephrine transporter (NET), also known as solute carrier family 6 member 2 (SLC6A2), is a protein that in humans is encoded by the SLC6A2 gene.
Methylphenidate and Norepinephrine transporter · Norepinephrine transporter and Selective serotonin reuptake inhibitor ·
Pethidine
Pethidine, also known as meperidine and sold under the brand name Demerol among others, is a synthetic opioid pain medication of the phenylpiperidine class.
Methylphenidate and Pethidine · Pethidine and Selective serotonin reuptake inhibitor ·
Phenelzine
Phenelzine (Nardil, Nardelzine) is a non-selective and irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class which is used as an antidepressant and anxiolytic.
Methylphenidate and Phenelzine · Phenelzine and Selective serotonin reuptake inhibitor ·
Placebo
A placebo is a substance or treatment of no intended therapeutic value.
Methylphenidate and Placebo · Placebo and Selective serotonin reuptake inhibitor ·
Prenatal development
Prenatal development is the process in which an embryo and later fetus develops during gestation.
Methylphenidate and Prenatal development · Prenatal development and Selective serotonin reuptake inhibitor ·
Priapism
Priapism is a condition in which a penis remains erect for hours in the absence of stimulation or after stimulation has ended.
Methylphenidate and Priapism · Priapism and Selective serotonin reuptake inhibitor ·
Receptor (biochemistry)
In biochemistry and pharmacology, a receptor is a protein molecule that receives chemical signals from outside a cell.
Methylphenidate and Receptor (biochemistry) · Receptor (biochemistry) and Selective serotonin reuptake inhibitor ·
Reuptake
Reuptake is the reabsorption of a neurotransmitter by a neurotransmitter transporter located along the plasma membrane of an axon terminal (i.e., the pre-synaptic neuron at a synapse) or glial cell after it has performed its function of transmitting a neural impulse.
Methylphenidate and Reuptake · Reuptake and Selective serotonin reuptake inhibitor ·
Reuptake inhibitor
A reuptake inhibitor (RI) is a type of drug known as a reuptake modulator that inhibits the plasmalemmal transporter-mediated reuptake of a neurotransmitter from the synapse into the pre-synaptic neuron.
Methylphenidate and Reuptake inhibitor · Reuptake inhibitor and Selective serotonin reuptake inhibitor ·
Serotonergic
Serotonergic or serotoninergic means "pertaining to or affecting serotonin".
Methylphenidate and Serotonergic · Selective serotonin reuptake inhibitor and Serotonergic ·
Serotonin syndrome
Serotonin syndrome (SS) is a group of symptoms that may occur following use of certain serotonergic medications or drugs.
Methylphenidate and Serotonin syndrome · Selective serotonin reuptake inhibitor and Serotonin syndrome ·
Serotonin transporter
The serotonin transporter (SERT or 5-HTT) also known as the sodium-dependent serotonin transporter and solute carrier family 6 member 4 is a protein that in humans is encoded by the SLC6A4 gene.
Methylphenidate and Serotonin transporter · Selective serotonin reuptake inhibitor and Serotonin transporter ·
Side effect
In medicine, a side effect is an effect, whether therapeutic or adverse, that is secondary to the one intended; although the term is predominantly employed to describe adverse effects, it can also apply to beneficial, but unintended, consequences of the use of a drug.
Methylphenidate and Side effect · Selective serotonin reuptake inhibitor and Side effect ·
Sigma-1 receptor
The sigma-1 receptor (σ1R), one of two sigma receptor subtypes, is a chaperone protein at the endoplasmic reticulum (ER) that modulates calcium signaling through the IP3 receptor.
Methylphenidate and Sigma-1 receptor · Selective serotonin reuptake inhibitor and Sigma-1 receptor ·
Stroke
A stroke is a medical condition in which poor blood flow to the brain results in cell death.
Methylphenidate and Stroke · Selective serotonin reuptake inhibitor and Stroke ·
Suicidal ideation
Suicidal ideation, also known as suicidal thoughts, is thinking about or having an unusual preoccupation with suicide.
Methylphenidate and Suicidal ideation · Selective serotonin reuptake inhibitor and Suicidal ideation ·
Tachycardia
Tachycardia, also called tachyarrhythmia, is a heart rate that exceeds the normal resting rate.
Methylphenidate and Tachycardia · Selective serotonin reuptake inhibitor and Tachycardia ·
Tranylcypromine
Tranylcypromine (contracted from trans-2-phenylcyclopropylamine; original trade name Parnate)Drugs.com.
Methylphenidate and Tranylcypromine · Selective serotonin reuptake inhibitor and Tranylcypromine ·
Tricyclic antidepressant
Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants.
Methylphenidate and Tricyclic antidepressant · Selective serotonin reuptake inhibitor and Tricyclic antidepressant ·
United Kingdom
The United Kingdom of Great Britain and Northern Ireland, commonly known as the United Kingdom (UK) or Britain,Usage is mixed with some organisations, including the and preferring to use Britain as shorthand for Great Britain is a sovereign country in western Europe.
Methylphenidate and United Kingdom · Selective serotonin reuptake inhibitor and United Kingdom ·
5-HT1A receptor
The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
5-HT1A receptor and Methylphenidate · 5-HT1A receptor and Selective serotonin reuptake inhibitor ·
The list above answers the following questions
- What Methylphenidate and Selective serotonin reuptake inhibitor have in common
- What are the similarities between Methylphenidate and Selective serotonin reuptake inhibitor
Methylphenidate and Selective serotonin reuptake inhibitor Comparison
Methylphenidate has 314 relations, while Selective serotonin reuptake inhibitor has 206. As they have in common 44, the Jaccard index is 8.46% = 44 / (314 + 206).
References
This article shows the relationship between Methylphenidate and Selective serotonin reuptake inhibitor. To access each article from which the information was extracted, please visit:
